Grabar Law Office Investigates Claims on Behalf of Shareholders of Ginkgo Bioworks Holdings, Inc. (DNA) f/k/a Soaring Eagle Acquisition Corp. (SRNG) After Securities Fraud Class Action Survives Motion to Dismiss

Philadelphia, Pennsylvania--(Newsfile Corp. - April 5, 2023) - A federal securities class action complaint against Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) F/K/A Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) and certain of its officers has survived a motion to dismiss.

Current long-term Ginkgo shareholders who acquired shares via the Soaring Eagle SPAC, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award at no cost to them whatsoever.

If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/ginkgo-bioworks-shareholder-investigation/, contact us at jgrabar@grabarlaw.com, or call 267-507-6085.

Attorney Advertising Disclaimer

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/161372